-Howard R Terebelo Researcher Activity Profile

Research Author Detailed Information 

Howard R Terebelo Publication Rate By Year

Howard R Terebelo has published 4 paper(s) in 2007, 2 paper(s) in 2008, for a total of 6 research publications in total.

Howard R Hr Terebelo Author Information

LAST NAME: terebelo

FIRST NAME: Howard R

INITIALS: hr

AFFILIATION:

Papers

Howard R Terebelo's Publication Record

1. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Year Published: 2007
Department of Microbiology and Immunology, University of Miami School of Medicine, FL, USA.
2. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington.
3. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu
4. Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). Year Published: 2007
Division of Medical Oncology, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium, Seattle, Washington 98109, USA. spetersd@u.washington.edu
5. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Year Published: 2008
Massachusetts General Hospital, Boston, MA 02114, USA. kuter.david@MGH.harvard.edu
6. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Year Published: 2008
Massachusetts General Hospital, Boston, MA 02114, USA. kuter.david@MGH.harvard.edu